4-(Benzyloxy)-5-chloro-2-fluorobenzaldehyde, 98%, 250mg

2(1H)-ISOQUINOLINEETHANAMINE, 3,4-DIHYDRO-6,7-DIMETHOXY-, 95.0%, 1g

4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-ol, 95.0%, 1g

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine hydrochloride, 97%, 10g

Ethyl 2-Bromopropionate>98.0%(GC)500g

4-Chloro-2-fluoroiodobenzene, 99.0%, 25g

N-([1,1'-Biphenyl]-4-yl)dibenzo[b,d]thiophen-4-amine, 98%, 1g

3-Phenylpyridin-2-ol, 95.0%, 1g

3-Bromo-4-fluorobenzenesulfonylchloride, 95.0%, 25g

(2E)-3-(4-ethoxy-3-methoxyphenyl)acrylic acid, 95.0%, 250mg

GC capillary column ROTI®Cap-5, 60 m, 0.32 mm, 1.00 µm, 1 Piece(s)

Tin(II) bromide 99% 50 g

(4-Chloro-2,6-dimethylphenyl)boronic acid, 95.0%, 250mg